Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
D000584:Amiloride / Q000494:pharmacology; D001485:Basement Membrane / Q000187:drug effects; D024141:Collagen Type IV / Q000378:metabolism; D017364:Collagenases / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism; D005260:Female; D018093:Gelatinases / Q000378:metabolism; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000209:etiology*; D010053:Ovary / Q000378:metabolism*; D010060:Ovulation; D012306:Risk; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D024141:Collagen Type IV; D014409:Tumor Necrosis Factor-alpha; D000584:Amiloride; D014568:Urokinase-Type Plasminogen Activator; D017364:Collagenases; D018093:Gelatinases; D020780:Matrix Metalloproteinase 9